Check Out What Whales Are Doing With BMY
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors are showing significant interest in Bristol-Myers Squibb (NYSE:BMY), with a notable increase in options activity. The sentiment is mixed, with 54% bullish and 45% bearish. Analysts have mixed ratings, with price targets ranging from $41 to $53.
August 16, 2024 | 5:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bristol-Myers Squibb has seen a surge in options activity, with 54% of investors bullish and 45% bearish. Analysts have mixed ratings, with price targets ranging from $41 to $53.
The significant increase in options activity suggests heightened interest and potential volatility in BMY's stock price. The mixed sentiment among investors and analysts indicates uncertainty, but the overall bullish tilt and high volume of trades point to a likely short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100